Choices in asthma and COPD care: How to maximize outcomes for patients

Professor Charlotte Suppli Ulrik took part in a very interesting session at this years ERS congress on how to maximize patients outcome in asthma and COPD. We asked her about the topic.

The digital age: The future of respiratory medicine

Prof. Henry Chrystyn speaks about asthma and COPD management. Where are we now, and where could we be in the future?

Pulmonary hypertension and interstitial pulmonary fibrosis

Prof. Cottin summarizes the main messages about the topic.

ERS/EAACI statement on adherence to international adult asthma guidelines

Doctor Alexander Mathioudakis summarizes the findings of an ERS/EAACI task force.

Severe asthma guidelines: Update 2019

Asthma is a common respiratory disorder, and the presentation of patients with acute, poorly controlled asthma remains a clinical challenge. Prof.  Andrew Bush speaks about the current guidelines.

Personalised medicine applied to inhaler selection

Professor Donald A. Mahler speaks about how to matching the patient with the right inhaler.

Resetting the agenda: a new approach to asthma in GINA 2019

Professor Alyn Hugh Morice speaks about the changes in the GINA recommendations in 2019 which were presented at a joint ERS-GINA symposium.

Hot topics in respiratory medicine and science

Professor Tobias Welte speaks about the novelties in the treatement of asthma, interstitial lung disease and infectious diseases.

Acute Respiratory Failure

Professor Clayton T. Cowl speaks about the newest findings of Acute Respiratory Failure.

Chronic Cough and Refractory Chronic Cough

Professor Alyn Hugh Morice speaks about the brand new guidelines about chronic cough.

Treatment with long term, low dose antibiotic could help people born with chronic lung condition

Taking a low dose of the antibiotic azithromycin for six months reduces symptoms for patients with the chronic lung condition primary ciliary dyskinesia (PCD), according to research presented at the European Respiratory Society International Congress.

Treatment considerations for comorbid patients with CAP: the complex made simple

Tackling resistant Gram-negative HAP/VAP: the role of a novel ß-lactam/ß-lactamase inhibitor

Putting it into practice: Interactive Pulmonary Arterial Hypertension patient case study"

Getting it right: How can we help our patients to manage their inhalers?

The Salford Lung Study in context: A paradigm shift in assessing asthma therapies

Role of immunoncology in lung cancer treatment

Immunotherapy in lung cancer

Important recent developments in oncology

EGFR and ALK mutations in NSCLC

Sequencing the mesothelioma genom

The proper treatment algorithm for non-oncogene driven NSCLC

Phase 2 trial of nivolumab in NSCLC

Multidisciplinary approach in lung cancer treatment

Immunotherapy as first-line treatment for NSCLC

LBA2_PR - EGFR mutation testing and oncologist treatment choice in advanced NSCLC

Role of checkpoint inhibitors in lung cancer treatment

Targeted therapy in lung cancer

The Lung Cancer Master Protocol

Surgical perspective of lung cancer treatment

Fight on tuberculosis

Launch of one of the world's largest ever lung health campaigns